SLX4 and cancer: In human, SLX4 is one of the genes mutated in Fanconi anemia (and is therefore also known as FANCP), a rare genetic disorder characterized by defective repair of replication-blocking inter-strand DNA crosslinks, genome instability, bone marrow failure and a high susceptibility to cancer [110,111].